Nanospectra Biosciences develops particle-based therapies for the selective and precise thermal destruction of solid tumors.
Nanospectra Biosciences has raised $6.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2023.
Nanospectra Biosciences's investors include Sirtex Medical.
Nanospectra Biosciences is headquartered in Houston, United States.
Nanospectra Biosciences develops particle-based therapies for the selective and precise thermal destruction of solid tumors.
Nanospectra Biosciences is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nanospectra Biosciences — Funding & Investors." VCBacked, March 15, 2023, https://www.vcbacked.co/company/nanospectra-biosciences. Accessed August 15, 2026.
VCBacked. (2023). Nanospectra Biosciences — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/nanospectra-biosciences
{{cite web |title=Nanospectra Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/nanospectra-biosciences |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated